恶唑啉|Oxazolines-毕得医药

关于我们|联系我们 400-600-5915|sales@picasso-e.com

登录 | 注册批量下单

搜索购物车会员中心

恶唑啉是一种含氧原子和氮原子的五元杂环化合物。它可能最早合成于1884年，但直到5年后，西格蒙·加布里埃尔才正确地指定了这种结构。它与Hantzsch–Widman命名法一致，是一族杂环化合物的一部分，在饱和度方面它存在于噁唑和噁唑烷之间。

按化学元素: B^x; C^x; N^x; O^x; F^x; Si^x; P^x; S^x; Cl^x; Br^x; I^x

母核：

官能团： 酯 (2) 芳基 (7) 酰胺 (1)

按纯度： 99+% 99% 98+% 98% 97+% 97% 96+% 96% 95+% 95% 93% 90+% 90%

按分子量： 0-100 100-200 200-300 300-400 400-500 500-600

按化学元素： CINO CNOSSi CNOP CClFNO CINOS CBrNO CFINO CNOSi CClNOS COS CNO CNOS CNOSe CFNOS CBrKNO CClFNOS CBrNOS CBrClNO CClNO CBrFNO CBrNOSe CFNO CFNOSe CBNO 更多

2,6-Bis((S)-4-isopropyl-4,5-dihydrooxazol-2-yl)pyridine 2,6-二[(4S)-4-异丙基-2-噁唑啉基]吡啶: BJS3893557118949-61-498% 99%ee; ￥323.001g

(S)-4-tert-Butyl-2-(2-pyridyl)oxazoline (S)-4-叔丁基-2-(2-吡啶基)恶唑啉: BJS5683540117408-98-798% 99%ee; ￥365.001g

(S,S)-4,4-Dimethyl-4,5,4',5'-tetrahydro [2.2]bioxazolyl (4S,4S')-4,4-二甲基-4,5,4',5'-四氢[2.2]双噁唑基: BJS4808985336884-31-298% 99%ee; ￥479.00250mg

(S)-N-(2-(4-Isopropyl-4,5-dihydrooxazol-2-yl)-6-methylphenyl)methanesulfonamide (S)-N-(2-(4-异丙基-4,5-二氢恶唑-2-基)-6-甲基苯基)甲磺酰胺: BJS6984460480444-15-395%; ￥2090.00100mg

(R)-4-Isopropyl-2-(quinolin-2-yl)-4,5-dihydrooxazole (R)-4-异丙基-2-(喹啉-2-基)-4,5-二氢噁唑: BJS2178951933992-49-597% 99%ee; ￥193.00250mg

(3aR,8aS)-2-(4-(Trifluoromethyl)pyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole (3aR,8aS)-2-(4-(三氟甲基)吡啶-2-基)-3a,8a-二氢-8H-茚并[1,2-d]噁唑: BJS33359822126903-00-097% 99%ee; ￥1495.00250mg

(4R,4'R)-2,2'-Methylenebis[4,5-dihydro-4-(1-methylethyl)oxazole] (4R,4'R)-2,2'-亚甲基双[4,5-二氢-4-(1-甲基乙基)噁唑]: BJS8410140164976-63-095%; ￥323.00250mg

(S)-2-(4-Methoxy-6-methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole (S)-2-(4-甲氧基-6-甲基吡啶-2-基)-4-苯基-4,5-二氢噁唑: BJS61820342757082-39-498%; ￥2062.00100mg

(S)-4-Benzyl-2-(4-methoxy-6-methylpyridin-2-yl)-4,5-dihydrooxazole (S)-4-苄基-2-(4-甲氧基-6-甲基吡啶-2-基)-4,5-二氢噁唑: BJS08828642757082-40-798%; ￥498.00100mg

(3aS,8aR)-2-(6-Methylpyridin-2-yl)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole (3aS,8aR)-2-(6-甲基吡啶-2-基)-3a,8a-二氢-8H-茚并[1,2-d]恶唑: BJS17183351532531-18-297% 99%ee; ￥1903.00250mg

(S)-4-((R)-sec-Butyl)-2-(pyridin-2-yl)-4,5-dihydrooxazole (S)-4-((R)-仲丁基)-2-(吡啶-2-基)-4,5-二氢恶唑: BJS62518872634687-84-497%; ￥2409.00250mg

(4S,4'S)-4,4'-Diisobutyl-4,4',5,5'-tetrahydro-2,2'-bioxazole (4S,4'S)-4,4'-二异丁基-4,4',5,5'-四氢-2,2'-联恶唑: BJS2776536138429-17-198%; ￥8484.001g

2,2-Bis((R)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)acetonitrile 2,2-双((R)-4-(叔丁基)-4,5-二氢恶唑-2-基)乙腈: BJS18389611442644-13-497%; ￥3669.00250mg

(R)-4-(tert-Butyl)-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole (R)-4-(叔丁基)-2-(6-甲基吡啶-2-基)-4,5-二氢恶唑: BJS40033712491654-89-697%; ￥2377.00100mg

(R)-4-Benzyl-2-(6-methylpyridin-2-yl)-4,5-dihydrooxazole (R)-4-苄基-2-(6-甲基吡啶-2-基)-4,5-二氢恶唑: BJS26552692757082-98-597% 99%ee; ￥2161.00100mg

(S)-2-(6-Methylpyridin-2-yl)-4-phenyl-4,5-dihydrooxazole (S)-2-(6-甲基吡啶-2-基)-4-苯基-4,5-二氢恶唑: BJS54230801308311-03-697%; ￥674.00100mg

(4R,5S)-2-(6-Methylpyridin-2-yl)-4,5-diphenyl-4,5-dihydrooxazole (4R,5S)-2-(6-甲基吡啶-2-基)-4,5-二苯基-4,5-二氢恶唑: BJS18306532417321-37-897% 99%ee; ￥1520.00100mg

(R)-4-Benzyl-2-(5-bromopyridin-2-yl)-4,5-dihydrooxazole (R)-4-苄基-2-(5-溴吡啶-2-基)-4,5-二氢恶唑: BJS94634802757083-32-097% 99%ee; ￥2203.00250mg

7-Bromo-2-methyl-2,3-dihydropyrazolo[5,1-b]oxazole 7-溴-2-甲基-2,3-二氢吡唑并[5,1-b]恶唑: BJS05199822676861-81-597%; ￥16170.001g

(S)-2-(Benzo[b]thiophen-2-yl)-4-ethyl-4,5-dihydrooxazole (S)-2-(苯并[b]噻吩-2-基)-4-乙基-4,5-二氢恶唑: BJS24369622828438-80-697%; ￥779.00100mg

1 2 3 4 5 6 7 8 9 ... 16